JPRN-jRCTs031180292已完成2 期
Intrapleural fibrinolytic therapy with urokinase
Yajima Toshiki0 个研究点目标入组 14 人开始时间: 2019年3月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
The intrathoracic application of urokinase for treatment of complicated pleural infections was effective in 85% of cases. There were severe adverse events in 15% of patients, which were considered to be related to the underlying comorbidity. The same patients required a surgical intervention.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patient with refractory intrathoracic infection
- •2. Patient with thoracic drain
- •3. Hospitalized patient
- •4. Patient with consent
排除标准
- •1.Patient with active intrathoracic bleeding
- •2. Patients considered unfit to participate by a doctor
研究者
相似试验
尚未招募
不适用
Intrapleural fibrinolytic therapy with urokinase.Refractory intrathoracic infectionJPRN-UMIN000031102Gunma University30
Unknown
不适用
Efficacy of Fibrinolytic Agents in Complicated Pleural EffusionComplicated Pleural Effusion/ EmpyemaNCT03716375Beijing Children's Hospital80
Unknown
3 期
Intrapleural Urokinase for Retained HemothoraxRetained HemothoraxNCT01134237National Taiwan University Hospital32
尚未招募
3 期
Early initiation of intra pleural streptokinase therapy versus placebo in the treatment of complicated pleural effusion in pediatric; An experience in tertiary care hospital.This study will be helpful in managing patients with complicated parapneumonic effusion by early intervention with instillation of intrapleural streptokinase.Intrapleural streptokinase, complicated pleural effusion, childrenTCTR20240411001The Children's Hospital Lahore & University of Child Health Sciences Lahore62
已完成
1 期
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionMesotheliomaBreast CancerLung CancerOvarian CancerMalignant Pleural EffusionNCT01997190Candel Therapeutics, Inc.19